Equity derivatives house - UBS

The past 12 months have been unfeasibly tough for UBS, as they have for nearly all financial institutions in Asia. But the bank has distinguished itself during this period by constantly striving to improve client service, no matter how hostile the operating conditions, offering consistently competitive pricing and seizing new opportunities.


One of those has been increased interest in the exchange-traded fund (ETF) business on the back of concerns about counterparty risk. "There was a decline in structured products as they are generally issued as notes - many clients decided to take a break, which created a new opportunity in the ETF space," says Christopher Lee, managing director for equity risk management products and head of cross-divisional intermediary business at the bank.

UBS has acted as a derivatives provider both to ETF

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact info@risk.net or view our subscription options here: http://subscriptions.risk.net/subscribe

You are currently unable to copy this content. Please contact info@risk.net to find out more.

Sorry, our subscription options are not loading right now

Please try again later. Get in touch with our customer services team if this issue persists.

New to Risk.net? View our subscription options

You need to sign in to use this feature. If you don’t have a Risk.net account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here